proinsulin human
Recombinant proteinexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2012 (NCT01536431)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
IGF1R agonist
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109212 ↗
Also known as
- proinsulin human
- proinsulin peptide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01536431 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2012 | Cardiff University, Juvenile Diabetes Research Foundation, University of London |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cardiff University | Academic/Hospital | 1 | 1 | 1 | 2012 |
| Juvenile Diabetes Research Foundation | Academic/Hospital | 1 | 0 | 1 | 2012 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2012 |
3 organizations
Page 1 / 1